Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Carcinoma in Situ”

Showing 4 of 0 results

Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT02993159
What this trial is testing

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor Positive
Northwestern University 100
Large-scale testing (Phase 3)Study completedNCT00402779
What this trial is testing

Erlotinib Prevention of Oral Cancer (EPOC)

Who this might be right for
Oral Cancer
M.D. Anderson Cancer Center 303
Not applicableStudy completedNCT01840436
What this trial is testing

Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer

Who this might be right for
Oral MucositisCarcinoma in Situ of Upper Respiratory Tract
Organ, Tissue, Regeneration, Repair and Replacement 136

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation